↓ Skip to main content

Chinese patent medicines for the treatment of the common cold: a systematic review of randomized clinical trials

Overview of attention for article published in BMC Complementary Medicine and Therapies, July 2014
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chinese patent medicines for the treatment of the common cold: a systematic review of randomized clinical trials
Published in
BMC Complementary Medicine and Therapies, July 2014
DOI 10.1186/1472-6882-14-273
Pubmed ID
Authors

Wei Chen, Bo Liu, Li-qiong Wang, Jun Ren, Jian-ping Liu

Abstract

Many Chinese patent medicines (CPMs) have been authorized by the Chinese State of Food and Drug Administration for the treatment of the common cold. A number of clinical trials have been conducted and published. However, there is no systematic review or meta-analysis on their efficacy and safety for the common cold to justify their clinical use.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 15%
Student > Bachelor 6 12%
Student > Postgraduate 5 10%
Student > Master 5 10%
Researcher 4 8%
Other 13 25%
Unknown 11 21%
Readers by discipline Count As %
Medicine and Dentistry 21 40%
Social Sciences 5 10%
Biochemistry, Genetics and Molecular Biology 3 6%
Psychology 3 6%
Nursing and Health Professions 2 4%
Other 5 10%
Unknown 13 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2014.
All research outputs
#20,265,771
of 22,796,179 outputs
Outputs from BMC Complementary Medicine and Therapies
#2,975
of 3,629 outputs
Outputs of similar age
#192,592
of 228,758 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#87
of 102 outputs
Altmetric has tracked 22,796,179 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,629 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,758 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.